- Home
- XGN vs OSUR Comparison
XGN vs OSUR Comparison
Compare XGN & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- OSUR
- Stock Information
- Founded
- XGN 2002
- OSUR 2000
- Country
- XGN United States
- OSUR United States
- Employees
- XGN N/A
- OSUR N/A
- Industry
- XGN Medical Specialities
- OSUR Medical/Dental Instruments
- Sector
- XGN Health Care
- OSUR Health Care
- Exchange
- XGN Nasdaq
- OSUR Nasdaq
- Market Cap
- XGN 210.4M
- OSUR 231.1M
- IPO Year
- XGN 2019
- OSUR 1986
- Fundamental
- Price
- XGN $11.04
- OSUR $3.02
- Analyst Decision
- XGN Strong Buy
- OSUR Hold
- Analyst Count
- XGN 5
- OSUR 1
- Target Price
- XGN $12.40
- OSUR $3.00
- AVG Volume (30 Days)
- XGN 258.8K
- OSUR 513.3K
- Earning Date
- XGN 11-11-2025
- OSUR 11-05-2025
- Dividend Yield
- XGN N/A
- OSUR N/A
- EPS Growth
- XGN N/A
- OSUR N/A
- EPS
- XGN N/A
- OSUR N/A
- Revenue
- XGN $58,862,000.00
- OSUR $138,533,000.00
- Revenue This Year
- XGN $22.28
- OSUR N/A
- Revenue Next Year
- XGN $14.03
- OSUR $4.32
- P/E Ratio
- XGN N/A
- OSUR N/A
- Revenue Growth
- XGN 3.89
- OSUR N/A
- 52 Week Low
- XGN $2.38
- OSUR $2.36
- 52 Week High
- XGN $11.28
- OSUR $4.60
- Technical
- Relative Strength Index (RSI)
- XGN 64.51
- OSUR 42.20
- Support Level
- XGN $10.63
- OSUR $3.10
- Resistance Level
- XGN $11.28
- OSUR $3.29
- Average True Range (ATR)
- XGN 0.38
- OSUR 0.11
- MACD
- XGN -0.00
- OSUR -0.03
- Stochastic Oscillator
- XGN 80.41
- OSUR 19.84
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.